Drug-delivery company Osmotica to announce expansion near Atlanta

The governor of Georgia is expected to announce on Thursday that global drug-delivery company Osmotica Pharmaceutical will spend about $30 million to build an R&D and manufacturing operation in Marietta, just outside Atlanta, according to the Atlanta Business Chronicle. The expansion is expected to add about 160 new jobs in the roughly 150,000-square-foot site, the paper reported.

Osmotica, which has operations in Wilmington, NC, Buenos Aires and Budapest, has a number of drug-delivery products in various stages of development focusing on treatment of Parkinson's disease, according to the company's website. The company also uses its Osmodex drug-delivery technology in partnerships with other companies. The Osmodex "family" of products "combines laser drilled tablet technology with variety of single active and multiple active drug delivery devices," according to the company.

Georgia's governor is expected to make the announcement at the site of the former Solvay Pharmaceuticals campus, which closed in early 2010 after Solvay was bought by Abbot Laboratories for $6.2 billion, the paper reported. The Atlanta Business Chronicle also says that the Osmotica expansion should diversify Georgia's life-science industry, "which is heavily weighted to early-stage companies."

- read more in the Atlanta Business Chronicle
- learn more about Osmodex

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.